Back
Protagonist Therapeutics Stock Price Chart
Google closes secret $20B deal with Apple to become iPhone's default search engine
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
$50.76
Seasonality Move:
13.71%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and PTGX is experiencing slight selling pressure.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.72 | Sell |
| 20-day SMA: | 46.21 | Buy |
| 50-day SMA: | 41.17 | Buy |
| 200-day SMA: | 40.77 | Buy |
| 8-day EMA: | 52.36 | Buy |
| 20-day EMA: | 48.25 | Buy |
| 50-day EMA: | 43.86 | Buy |
| 200-day EMA: | 39.43 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.16 | Buy |
| Relative Strength Index (14 RSI): | 63.23 | Buy |
| Chaikin Money Flow: | -182051 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.27 - 53.03) | Buy |
| Bollinger Bands (100): | (36.52 - 47.34) | Buy |
Protagonist Therapeutics Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 52.53 while PTGX 8-day simple moving average is 53.72, which is a Sell signal.
-
The stock price of PTGX is 52.53 while Protagonist Therapeutics 20-day SMA is 46.21, which makes it a Buy.
-
Protagonist Therapeutics 50-day simple moving average is 41.17 while PTGX share price is 52.53, making it a Buy technically.
-
PTGX stock price is 52.53 and Protagonist Therapeutics 200-day simple moving average is 40.77, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a BuyThe current Protagonist Therapeutics [PTGX] share price is $52.53. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
3.2B
Price in USD:
52.53
Share Volume:
1.5M
Protagonist Therapeutics 52-Week Range
52-Week High:
60.60
52-Week Low:
24.22
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?The Protagonist Therapeutics stock price is 52.53 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is not overvalued.
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 52.53 while PTGX 8-day exponential moving average is 52.36, which is a Buy signal.
-
The stock price of PTGX is 52.53 while Protagonist Therapeutics 20-day EMA is 48.25, which makes it a Buy.
-
Protagonist Therapeutics 50-day exponential moving average is 43.86 while PTGX share price is 52.53, making it a Buy technically.
-
PTGX stock price is 52.53 and Protagonist Therapeutics 200-day simple moving average is 39.43, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.08 per share, a decrease this year of $3.86 per share, and an increase next year of $0.16 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is 4.16, suggesting Protagonist Therapeutics is a Buy
-
Protagonist Therapeutics Relative Strength Index (RSI) is 63.23, which suggest Protagonist Therapeutics is overbought
-
The Bollinger Bands (25) for Protagonist Therapeutics is (36.27 - 53.03), which suggest Protagonist Therapeutics is a Buy
-
The Bollinger Bands (100) for Protagonist Therapeutics is (36.52 - 47.34), which suggest Protagonist Therapeutics is a Buy
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.